Suppr超能文献

聚乙二醇-脂质缀合物可调节由磷脂酰乙醇胺和磷脂酰丝氨酸组成的脂质体的钙诱导融合。

Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine.

作者信息

Holland J W, Hui C, Cullis P R, Madden T D

机构信息

Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.

出版信息

Biochemistry. 1996 Feb 27;35(8):2618-24. doi: 10.1021/bi952000v.

Abstract

The effect of poly(ethylene glycol)--lipid (PEG--lipid) conjugates on liposomal fusion was investigated. Incorporation of PEG--lipids into large unilamellar vesicles (LUVs) composed of equimolar phosphatidylethanolamine (PE) and phosphatidylserine (PS) inhibited calcium-induced fusion. The degree of inhibition increased with increasing molar ratio of the PEG conjugate and with increasing size of the PEG moiety. Inhibition appeared to result from the steric barrier on the surface of the liposomes which opposed apposition of bilayers and interbilayer contact. In the presence of a large excess of neutral acceptor liposomes, however, fusogenic activity was restored. The rate of fusion under these conditions depended on the initial molar ratio of the PEG conjugate in the PE:PS vesicles and the length and degree of saturation of the acyl chains which composed the lipid anchor. These results are consistent with spontaneous transfer of the PEG--lipid from PE:PS LUVs to the neutral lipid sink reducing the steric barrier and allowing fusion of the PE:PS LUVs. The primary determinant of the rate of fusion was the rate of transfer of the PEG--lipid, indicating that liposomal fusion could be programmed by incorporation of appropriate PEG--lipid conjugates. Interestingly, increasing the size of the PEG group did not appear to affect the rate of fusion. The implications of these results with respect to the design of fusogenic liposomal drug delivery systems are discussed.

摘要

研究了聚乙二醇-脂质(PEG-脂质)缀合物对脂质体融合的影响。将PEG-脂质掺入由等摩尔磷脂酰乙醇胺(PE)和磷脂酰丝氨酸(PS)组成的大单层囊泡(LUVs)中可抑制钙诱导的融合。抑制程度随PEG缀合物摩尔比的增加以及PEG部分尺寸的增大而增加。抑制作用似乎是由于脂质体表面的空间位垒阻碍了双层膜的并列和层间接触。然而,在存在大量中性受体脂质体的情况下,融合活性得以恢复。在这些条件下的融合速率取决于PE:PS囊泡中PEG缀合物的初始摩尔比以及构成脂质锚定的酰基链的长度和饱和度。这些结果与PEG-脂质从PE:PS LUVs自发转移到中性脂质库中从而降低空间位垒并允许PE:PS LUVs融合是一致的。融合速率的主要决定因素是PEG-脂质的转移速率,这表明可以通过掺入合适的PEG-脂质缀合物来调控脂质体融合。有趣的是,增加PEG基团的尺寸似乎并未影响融合速率。讨论了这些结果对融合性脂质体药物递送系统设计的意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验